Results 141 to 150 of about 820 (178)

Approach to a Child with Hypophosphatemia. [PDF]

open access: yesBiomolecules
Antonowicz A   +3 more
europepmc   +1 more source

Toxicity and efficacy of antibody-drug conjugates in advanced solid tumors: a retrospective single-center analysis of clinical trials. [PDF]

open access: yesESMO Open
Woodford R   +8 more
europepmc   +1 more source

Supplementary Table 2 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile

open access: gold
Annette M. Vogl   +19 more
openalex   +1 more source

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy. [PDF]

open access: yesNat Commun
Wamba BEN   +10 more
europepmc   +1 more source

Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. [PDF]

open access: yesCancers (Basel)
Sato S   +11 more
europepmc   +1 more source

Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients [PDF]

open access: yes
A Bellasi   +58 more
core   +1 more source

Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates. [PDF]

open access: yesMol Cancer Ther
Petersen ME   +20 more
europepmc   +1 more source

Supplementary Methods 1 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile

open access: gold
Annette M. Vogl   +19 more
openalex   +1 more source

Home - About - Disclaimer - Privacy